Zopiclone
| Zopiclone | |
|---|---|
| Salts [] | |
|---|---|
| Zopiclone hydrochloride | |
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 388.80 g/mol [1] |
| Melting point | 178 °C [1] |
| Solubility | 0.151 mg/mL at 25 °C [1] |
| Predicted LogP | 0.5 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C17H17ClN6O3 |
| IUPAC name | [6-(5-chloro-2-pyridinyl)-5-oxo-7H-pyrrolo[3,4-b]pyrazin-7-yl] 4-methylpiperazine-1-carboxylate |
| SMILES | CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl |
| InChI | InChI=1S/C17H17ClN6O3/c1-22-6-8-23(9-7-22)17(26)27-16-14-13(19-4-5-20-14)15(25)24(16)12-3-2-11(18)10-21-12/h2-5,10,16H,6-9H2,1H3 |
| InChIKey | GBBSUAFBMRNDJC-UHFFFAOYSA-N |
| CAS number | 43200-80-2 |
| UNII | 03A5ORL08Q |
| PubChem CID | 5735 |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | ~5 hours (3.5–6.5 hours) , ~7–9 hours for 65+ years old |
| Metabolism | Hepatic through CYP3A4 and CYP2E1 |
| Excretion | Urine (80%) |
| Routes of administration | By mouth |
| Dependence liability | High |
| Addiction liability | High |
| Dosing[] |
|---|
| Sublingual [] | |
|---|---|
| Light | ≤ 6.8 mg(6x - 27.3%) |
| Common | 6.8 - 8.8 mg(5x - 22.7%) |
| Strong | 8.8 - 10 mg(7x - 31.8%) |
| Heavy | 10 - 14.7 mg(1x - 4.5%) |
| Extreme | 14.7 mg +(3x - 13.6%) |
| Oral [] | |
|---|---|
| Light | ≤ 13.2 mg(10x - 47.6%) |
| Common | 13.2 - 20 mg(5x - 23.8%) |
| Strong | 20 - 22.5 mg(1x - 4.8%) |
| Heavy | 22.5 - 30 mg(5x - 23.8%) |
| Extreme | 30 mg + |
Statistically derived dosages via DBI-IGS (archived by anodyne.wiki) We do not take any responsibility for medical complications or loss of life sustained by following these dosages blindly. |
Zopiclone (also known as Imovane, Zimovane, Amoban, (+-)-Zopiclone, Zopiclona, Zopiclonum, Ximovan, Rp-27267, Zimovane LS or Rp 27267) is a substance of the cyclopyrrolone class.
Chemistry
Salts []
Stereochemistry []
Zopiclone is a racemic mixture of the enantiomers (optical activity ( + / - )).
Druglikeness
Lipinski's rule of five
Zopiclone matches Lipinski's rule of five.Reagents
There are currently 3 reagent-interactions on DrugsPRO
| Reagent | Color change | Description |
|---|---|---|
| Marquis | no color change | |
| Mecke | no color change | |
| Mandelin | no color change |
Pharmacology
ATC Classification
- nervous system (N)
- psycholeptics (N05)
- hypnotics and sedatives (N05C)
- benzodiazepine related drugs (N05CF)
- (N05CF01)
- zopiclone (N05CF01)
MeSH Classification
- hypnotics and sedatives (M0010885)
Mechanism of action []
Zopiclone exerts its action by binding on the benzodiazepine receptor complex and modulation of the GABA<sub>B</sub>Z receptor chloride channel macromolecular complex. Both zopiclone and benzodiazepines act indiscriminately at the benzodiazepine binding site on α1, α2, α3 and α5 GABAA containing receptors as full agonists causing an enhancement of the inhibitory actions of GABA to produce the therapeutic (hypnotic and anxiolytic) and adverse effects of zopiclone. [1]
Interactions []
Interaction mechanisms documented in KEGG DRUG (number of interacting drugs):
| CYP3A4 | metabolism / inhibition / induction | 217 |
|---|---|---|
| GABRA1 | shared target | 29 |
| GABRA2 | shared target | 27 |
| GABRA3 | shared target | 27 |
| GABRA4 | shared target | 27 |
| GABRA5 | shared target | 27 |
| GABRA6 | shared target | 27 |
| GABRB1 | shared target | 27 |
| GABRB2 | shared target | 27 |
| GABRB3 | shared target | 27 |
| GABRD | shared target | 27 |
| GABRE | shared target | 27 |
| GABRG1 | shared target | 27 |
| GABRG2 | shared target | 27 |
| GABRG3 | shared target | 27 |
| GABRP | shared target | 27 |
| GABRQ | shared target | 27 |
Medical side effects []
243 side effects listed on drug labels in SIDER 4.1 (zopiclone).
- Headache
- Somnolence
- Drowsiness
- Infection
- Dry mouth
- Dizziness
- Lightheadedness
- Chest pain
- Oedema peripheral
- Migraine
- Dyspepsia
- Heartburn
- Digestion impaired
- Nausea
- Pain
- Dermatitis
- Rash
- Diarrhoea
- Viral infection
- Depression
- Pruritus
- Anxiety
- Hallucination
- Abnormal dreams
- Confusional state
- Feeling abnormal
- Malaise
- Libido decreased
- Disturbance in sexual arousal
- Dysmenorrhoea
- Gynaecomastia
- Neuralgia
- Urinary tract infection
- Vomiting
- Injury
- Nervousness
- Tension
- Alopecia
- Amenorrhoea
- Anaemia
- Decreased appetite
- Arthritis
- Asthma
- Ataxia
- Bronchitis
- Bursitis
- Cellulitis
- Cholelithiasis
- Conjunctivitis
- Cystitis
- Bladder pain
- Cystitis noninfective
- Dermatitis contact
- Dyspnoea
- Dysuria
- Ear pain
- Eczema
- Epistaxis
- Body temperature increased
- Breath odour
- Heat stroke
- Haematuria
- Hernia
- Hiccups
- Hostility
- Hypercholesterolaemia
- Hypersensitivity
- Hypertension
- Hypoaesthesia
- Numbness
- Nephrolithiasis
- Laryngitis
- Muscle spasms
- Cramp muscle
- Mastitis
- Breast pain
- Melaena
- Menorrhagia
- Prolonged menses
- Metrorrhagia
- Hypertonia
- Neurosis
- Nystagmus
- Otitis externa
- Otitis media
- Paraesthesia
- Tingling of extremity
- Tingling sensation
- Mouth ulceration
- Hyperhidrosis
- Swelling
- Thirst
- Tinnitus
- Pollakiuria
- Urinary incontinence
- Urticaria
- Uterine haemorrhage
- Vaginal inflammation
- Vaginal infection
- Vertigo
- Vestibular disorder
- Weight increased
- Weight decreased
- Agitation
- Apathy
- Flat affect
- Mood swings
- Affect lability
- Breast engorgement
- Stomatitis
- Musculoskeletal stiffness
- Stiffness
- Nuchal rigidity
- Galactorrhoea
- Hyporeflexia
- Skin discolouration
- Dry skin
- Sickness
- Discomfort
- Ill-defined disorder
- Muscle twitching
- Increased appetite
- Thinking abnormal
- Mental disability
- Memory impairment
- Dry eye
- Photosensitivity reaction
- Lymphadenopathy
- Coordination abnormal
- Face oedema
- Renal pain
- Insomnia
- Muscular weakness
- Breast neoplasm
- Breast enlargement
- Vaginal haemorrhage
- Arthropathy
- Osteoarthritis
- Colitis
- Dysphagia
- Dehydration
- Erythema multiforme
- Furuncle
- Gastritis
- Gout
- Hepatitis
- Hepatomegaly
- Herpes zoster
- Hirsutism
- Hyperaesthesia
- Hyperlipidaemia
- Hypokalaemia
- Iritis
- Myopathy
- Mydriasis
- Neuritis
- Neuropathy peripheral
- Neuropathy
- Oliguria
- Pyelonephritis
- Hyperacusis
- Gastric ulcer
- Thrombophlebitis
- Tremor
- Urethritis
- Urethritis noninfective
- Stupor
- Depressed level of consciousness
- Photophobia
- Hypokinesia
- Tongue disorder
- Tongue oedema
- Hepatocellular injury
- Liver injury
- Rash pustular
- Dermatitis bullous
- Euphoric mood
- Parosmia
- Rectal haemorrhage
- Rash maculo-papular
- Gait disturbance
- Abdominal pain
- Gastrointestinal pain
- Congenital anomaly
- Developmental delay
- Aggression
- Alcohol poisoning
- Amblyopia
- Amnesia
- Memory loss
- Retrograde amnesia
- Anaphylactic shock
- Anger
- Angioedema
- Asthenia
- Fatigue
- Back pain
- Abnormal behaviour
- Tongue coated
- Constipation
- Delirium
- Delusion
- Depersonalisation
- Diplopia
- Drug hypersensitivity
- Dysgeusia
- Taste bitter
- Taste metallic
- Illusion
- Influenza
- Irritability
- Hypotonia
- Muscle relaxant therapy
- Nightmare
- Sensory loss
- Palpitations
- Pharyngitis
- Pregnancy
- Respiratory tract infection
- Rhinitis
- Convulsion
- Salivary hypersecretion
- Somnambulism
- Speech disorder
- Withdrawal syndrome
- Tachycardia
- Chills
- Panic attack
- Drug withdrawal syndrome
- Aspartate aminotransferase increased
- Myalgia
- Musculoskeletal discomfort
- Gastrointestinal disorder
- Derealisation
- Anterograde amnesia
- Sedation
- Erectile dysfunction
- Drug intolerance
- Ejaculation failure
- Vision blurred
- Suicidal ideation
- Laboratory test abnormal
- Libido disorder
Indications
- Chronic insomnia
- Insomnia
- Mental disorder
- Nocturnal awakening
- Sleep disturbance
- Wave slowing
Subjective effects []
| emily / Zopiclone [] | |
|---|---|
Routes:
| |
| magnus / Zopiclone [] | |
|---|---|
Routes:
| |
| nervewing / Zopiclone [] | |
|---|---|
| Pilz / Zopiclone [] | |
|---|---|
Routes:
| |
| vivi / Zopiclone [] | |
|---|---|
Routes:
| |
Experience reports
- "There are 45 psychedelic and dissociative trip reports in the Drug Users Bible: Download a free copy from here. Whether psychedelics are used for recreation, you need to look after yourself. Stay safe." by DMTrott (3 upvotes)
- "750mg DPH + 190mg Mirtazapine + 80mg Cinolazepam + 15mg Zopiclone trip report" by -ZoXoXoZ- (1 upvotes)
- "(LSD) Did I take fake acid?" by psilocybinposeidon (1 upvotes)
Legal status []
- Australia: Zopiclone is a Schedule 4.[3]
- Brazil: Zopiclone is a B1.[4]
- Canada: Zopiclone is Prescription only.
- United Kingdom: Zopiclone is a Class C under the "Misuse of Drugs Act 1971".
- New Zealand: Zopiclone is a Class C5 -restricted.[5]
- United States: Zopiclone is a Schedule IV under the "Controlled Substances Act".
- Other: Zopiclone is a SE: Förteckning V, In general: ℞ (Prescription only).[6]
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 5735, Zopiclone. Accessed November 20, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/5735
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Zopiclone. UNII: 03A5ORL08Q. Global Substance Registration System. Accessed November 20, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/03A5ORL08Q
Therapeutic Goods (Poisons Standard— June 2025) Instrument 2025. Therapeutic Goods Administration (TGA). May 2025. https://www.legislation.gov.au/F2025L00599/asmade/2025-05-28/text/original/pdf
RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-03-31. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992
Imovane Datasheet. Medsafe NZ. https://www.medsafe.govt.nz/profs/datasheet/i/imovanetab.pdf
Imovane®, Tablett 5 mg. FASS.se. 17 October 2022. https://fass.se/health/product/19910816000041/fass-text
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | ok | 2026-11-20 11:07:13 |
| drugspro | ok | 2026-11-20 11:07:09 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 11:07:09 |
| gsrs | ok | 2026-11-20 11:07:10 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0015329) | 2026-11-20 11:07:09 |
| kegg | ok | 2026-11-20 11:07:11 |
| pubchem | ok | 2026-11-20 11:07:08 |
| ok | 2026-11-20 11:07:09 | |
| sider | ok | 2026-11-20 11:07:09 |
| structure | ok | 2026-11-20 11:07:09 |
| wikipedia | ok | 2026-11-20 11:07:09 |